The new rule requires sponsors to report antimicrobial sales estimates that are species-specific. The resulting acquired data will complement larger information being gathered in collaboration with the CDC and the U.S. Department of Agriculture. The cooperative effort aims to reduce the prevalence of antibiotic resistant bacteria.
William T. Flynn, deputy director for science policy at the FDA’s Center for Veterinary Medicine, said, “This information will further enhance FDA’s ongoing activities related to slowing the development of antimicrobial resistance to help ensure that safe and effective antimicrobial new animal drugs will remain available for use in human and animal medicine.”
More articles on population health:
NYC says bartenders can’t refuse to serve pregnant women alcohol
NIH grants NYU $1.6 million to study biological and physiological effects of e-cigs
CDC report: 34% of American adults did not see, talk to a physician last year
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
